Bank of Montreal’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
AI
Bank of Montreal's CRL Position: Q2 2026 in Review
Bank of Montreal increased its Charles River Laboratories (CRL) stake by 3.1% in Q2 2026, buying an estimated $2.48M and bringing the position to 459,768 shares worth $104M. The position accounts for 0.03% of the portfolio, ranked #384.
Bank of Montreal first reported a position in CRL in Q2 2013 and has held it in 53 quarters since. 570 funds tracked by Wall St. Rank hold CRL as of Q2 2026.
- Bank of Montreal held 459,768 shares of Charles River Laboratories worth $104M as of Q2 2026.
- Bank of Montreal bought 13,899 Charles River Laboratories shares in Q2 2026, an estimated $2.48M.
- Charles River Laboratories made up 0.03% of Bank of Montreal's portfolio in Q2 2026, its #384 holding.
- Bank of Montreal first reported a position in Charles River Laboratories in Q2 2013 and has held it in 53 quarters since.
- 570 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.